课题基金 / 基金详情

Osteoblast-specific CGRP receptor -expression of osteoblastic differentiation-independent non-type I CGRP receptor-

Osteoblast-specific CGRP receptor -expression of osteoblastic differentiation-independent non-type I CGRP receptor-
成骨细胞特异性 CGRP 受体 -成骨细胞分化独立的非 I 型 CGRP 受体的表达 -
批准号:
16591855
负责人:
KAWASE Tomoyuki
金额:
$2.05万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2006

项目摘要

项目成果

KAWASE Tomoyuki的其他基金

相似基金

相关文献

中文摘要
翻译
1)在人成骨细胞MG 63中,CGRP(1-100 nM)诱导瞬时Ca^<2+>峰和随后的胞浆游离Ca^<2+>浓度([Ca^<2+]_i)缓慢增加。在大鼠成骨细胞UMR 106中未观察到第二时相。CGRP还可诱导质膜超极化。CGRP Ⅰ型受体(CGRP-R1)的拮抗剂CGRP_1可使这种作用减弱约50%<8-37>。2)CGRP诱导的细胞反应Schild图分析在MG 63细胞中,CGRP诱导的细胞反应,如cAMP产生、p38-MAPK磷酸化和CREB磷酸化,被鉴定为由同一个CGRP受体亚型介导,可能是CGRP-R1。相反,CGRP诱导的ERK去磷酸化被认为是由单个未知亚型的CGRP受体或由CGRP-R1和未知受体亚型的组合介导的。3)肾上腺髓质素、降钙素及其特异性拮抗剂对细胞内信号通路的影响除MG 63细胞外,本文还使用了人牙周膜细胞。肾上腺髓质素(ADM)和降钙素(CT)在较高浓度(1 μM)时均能模拟CGRP的作用,但其特异性拮抗剂ADM_<22-52>2和CT_3<8-32>不能明显阻断CGRP的作用。这些结果表明,我们所观察到的CGRP的作用不是由ADM受体或CT受体介导的,而是由CGRP特异性受体亚型介导的。
英文摘要
1) Effects of CGRP on cytoplasmic Ca^<2+> mobilization and membrane potentialIn human osteoblastic MG63 cells, CGRP (1-100 nM) induced a transient Ca^<2+> spike and a subsequent slow increment in cytoplasmic free Ca^<2+> concentrations ([Ca^<2+>]_i). The second phase was not observed in rat osteoblastic UMR106 cells. CGRP also induced plasma membrane hyperpolarization. This action was attenuated only approximately 50% by an antagonist of CGRP subtype I receptor (CGRP-R1), CGRP_<8-37>. These findings suggest that These CGRP actions are not solely mediated by known CGRP-R1 but also by other non-subtype I receptors.2) Schild plot analysis of CGRP-induced cellular responsesIn MG63 cells, the CGRP-induced cellular responses, such as cAMP production, p38-MAPK phosphorylation, and CREB phosphorylation, were identified to be mediated by the same single CGRP receptor subtype, probably CGRP-R1. In contrast, CGRP-induced ERK dephosphorylation was suggested to be mediated either by a single unknown subtype of CGRP receptor or by a combination of CGRP-R1 and a unknown receptor subtype(s).3) Effects of adrenomedullin, calcitonin, and their specific antagonists on intracellular signaling pathwaysIn addition to MG63 cells, human periodontal ligament cells were employed here. Both adrenomedullin (ADM) and calcitonin (CT) at higher concentrations (1 μM) mimicked CGRP action, but their specific antagonists, such as ADM_<22-52> and CT_<8-32>, failed to significantly block CGRP action. These findings suggest that CGRP actions we have observed are not mediated either by ADM receptor or CT receptor, but by several CGRP-specific receptor subtypes.
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
Immature osteoblastic MG63 cells possess two calcitonin gene-related peptide receptor subtypes that differentially respond to [Cys(Acm)^<2, 7>]-CGRP and CGRP_<8-37>.
未成熟的成骨细胞MG63细胞具有两种降钙素基因相关肽受体亚型,它们对[Cys(Acm)^<2, 7>]-CGRP和CGRP_<8-37>有不同的反应。
DOI: --
发表时间: 2005
期刊: Am J Physiol Cell Physiol 289・4
影响因子: --
作者: [Kawase T, Okuda K, Burns DM]
通讯作者: Burns DM
Immature osteoblastic MG63 cells possess two calcitonin gene-related peptide receptor subtypes that differentially respond to [Cys(Acm)^<2,7>]-CGRP and CGRP_<8-37>.
未成熟的成骨细胞MG63细胞具有两种降钙素基因相关肽受体亚型,它们对[Cys(Acm)^<2,7>]-CGRP和CGRP_<8-37>有不同的反应。
DOI: --
发表时间: 2005
期刊: American Journal of Physiology (Cellular Physiology) 289・4
影响因子: --
作者: [Kawase T, Okuda K, Burns DM]
通讯作者: Burns DM
Immature osteoblastic MG63 cells possess two calcitonin gene-related peptide receptor subtypes that differentially respond to [Cys(Acm)^<2.7>]-CGRP and CGRP_<8-37>.
未成熟的成骨细胞MG63细胞具有两种降钙素基因相关肽受体亚型,其对[Cys(Acm)^<2.7>]-CGRP和CGRP_<8-37>有不同的反应。
DOI: --
发表时间: 2005
期刊: AM J Physiol Cell Physiol 289(4)
影响因子: --
作者: [Kawase T, Okuda K, Burns DM]
通讯作者: Burns DM
DOI: 10.1152/ajpcell.00274.2003
发表时间: 2004-08-01
期刊: AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
影响因子: 5.5
作者: [Burns, DM, Stehno-Bittel, L, Kawase, T]
通讯作者: Kawase, T
Tissue-engineering of cartilage by the use of alveolar bone-derived periosteal sheets
  • 批准号:
    24659872
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
  • 资助金额:
    $2.33万
  • 财政年份:
    2012
  • 负责人:
    KAWASE Tomoyuki
  • 依托单位:
Developments of scaffolds and processing technology to maximize the osteogenic potential of cultured periosteal sheets
  • 批准号:
    21592492
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.91万
  • 财政年份:
    2009
  • 负责人:
    KAWASE Tomoyuki
  • 依托单位:
Three-dimensional high density culture of periodontal ligament cells on porous Hap blocks and their osteogenic induction
  • 批准号:
    19592140
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.0万
  • 财政年份:
    2007
  • 负责人:
    KAWASE Tomoyuki
  • 依托单位:
Studies on CGRP receptor subtypes and their specific intracellular signaling pathways in the periodontal tissue
  • 批准号:
    12671803
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.11万
  • 财政年份:
    2000
  • 负责人:
    KAWASE Tomoyuki
  • 依托单位:
国内基金
海外基金
Foxc2介导Syap1/Akt信号通路调控破骨/成骨细胞分化促进颞下颌关节骨关节炎的机制研究
  • 批准号:
    82370979
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    张善勇
  • 依托单位:
仿生膜构建破骨细胞融合纳米诱饵用于骨质疏松治疗的研究
  • 批准号:
    82372098
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    倪大龙
  • 依托单位:
组蛋白乙酰化修饰ATG13激活自噬在牵张应力介导骨缝Gli1+干细胞成骨中的机制研究
  • 批准号:
    82370988
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    经典
  • 依托单位:
先天型成骨不全骨量失衡的病理机制及动物模型的研究
  • 批准号:
    30973070
  • 项目类别:
    面上项目
  • 资助金额:
    33.0万元
  • 批准年份:
    2009
  • 负责人:
    张浩
  • 依托单位: